Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-25-000018

Chief Accounting Officer gave up 1,586 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Mossler Mark · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-02-14 Shares withheld for taxes : show line 1 in the form −1,586 $3.18 $5,043 18,204 D
Loading xslF345X05/wk-form4_1739915700.xml…